Alleviation of Hyperlipidemia, Insulin Resistance, and Myopathy by Nano Selenium/Nano CoQ10 Platform with Simvastatin in Hyperlipidemic Rats: Comprehensive Outlook

    January 2023 in “ Research Square (Research Square)
    Hagar B. Abo-zalam, Ezz ElDeen Saeed El Denshary, Rania A. Abdalsalam, Islam A. Khalil, Mahmoud M. Khattab, Mohamed A. Hamzawy
    Image

    Preprint — not peer reviewed. This was posted to a preprint server or data repository. It has not been through a journal's review process, and its findings may change or not hold up.

    Studysummary In this study, CoQ10 and selenium nanoparticles showed potential to alleviate hyperlipidemia and simvastatin-induced side effects in rats, but a triple combination with simvastatin caused intense liver and muscle damage.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →